Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2025 | Story Onthatile Tikoe | Photo Supplied
Logan James
Logan W. James, UFS alumnus and breakout star of Binnelanders Season 15, proudly waves the Kovsie flag as he steps into his first national television role.

University of the Free State (UFS) alumnus Logan W James made his national television debut in Season 15 of kykNET’s long-running medical drama, Binnelanders. Streaming on Showmax from 4 June 2025, the latest season introduces Logan in a role that delivers high drama, high energy, and a fresh wave of talent rooted in the Free State.

 

From campus to camera

Born and bred in Bloemfontein, Logan’s rise from student theatre to the small screen is a story stitched together by grit, passion, and a deep love for performance. A former learner of Grey College and a proud Kovsie, Logan honed his craft at the University of the Free State, where he quickly became known for his magnetic stage presence and commitment to his roles.

From standout performances in Everyman, How to Wuzz, and Run for Your Wife to unforgettable moments during UFS’s annual Africa Day showcases, Logan carved out a name for himself as a rising star on campus – one performance at a time.

 

A dream years in the making

Now based in Johannesburg, Logan is stepping into a new kind of spotlight. He plays Le Roux Snyman - a thrill-seeking, motocross-riding character with a bold facade and hidden depths.

“Le Roux is full of energy and contradictions,” Logan says. “He lives for extreme sports and adrenaline, but there’s a much softer, more vulnerable side he doesn’t often show. What excites me is exploring both boldness and fragility in the same breath - it’s something I’ve never quite done before.”

Though this may be Logan’s TV debut, stepping onto the Binnelanders set felt strangely familiar.

“I used to watch Binnelanders at my grandmother’s house,” he recalls. “Never in my wildest dreams did I imagine I’d one day be part of the cast. It feels like a full-circle moment - a dream realised. The journey here wasn’t straightforward, but seeing it come to life like this is an incredible blessing.”

 

The foundation of theatre

Logan credits his Bloemfontein theatre roots as the foundation of his acting journey. “Theatre taught me discipline, presence, and heart,” he says. “On stage, there are no second takes. You have to show up, fully and honestly, every time. That kind of intensity trains you not as a performer, but as a professional.

These lessons continue to shape how he approaches his work today. “Kindness and professionalism – those are the two things I carry into every production,” he adds.

 

Big city, bigger lessons

The move from Bloem’s close-knit creative community to the bustling entertainment industry in Johannesburg came with new challenges – and new lessons.

“In Joburg, you quickly realise just how much talent is out there,” Logan says. “It forced me to embrace what makes me unique, rather than compare myself to others. Real passion – not the pursuit of fame – is what carries you through the tough times. If you’re chasing the art, not the spotlight, you’ll find purpose, even when things get hard.”

 

A voice for regional talent

Logan’s journey is not just a personal triumph – it’s also a win for regional talent. As a Free State-born actor breaking into the national scene, he is part of a growing wave of creatives proving that national recognition is possible from anywhere.

“To go from student theatre to national TV is a leap that’s both terrifying and thrilling,” Logan reflects. “But it's proof that consistent hard work, staying true to your craft, and trusting the process can open doors you once only dreamed of.”

 

Ready for the spotlight

With his first episode having aired on 4 June, audiences were treated to a performance that was rich with energy and layered with emotion.

“There’s a lot of growth ahead - for Le Roux and for me,” Logan shares. “I’m looking forward to every moment of it. I can’t wait for South Africa to meet him.”

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept